SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

NovoCure Q3'26 Earnings Preview: Revenue Estimate

NovoCure is scheduled to report Q3'26 results on October 29 before the market opens. EPS is anticipated at $(0.23).

NVCR

Related stories